Target- |
MechanismCell replacements |
|
|
|
|
Drug Highest PhasePhase 2/3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with StemCutis, LLC,
0 Patents (Medical) associated with StemCutis, LLC,
100 Deals associated with StemCutis, LLC,
100 Translational Medicine associated with StemCutis, LLC,